Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Costs per Treatment Phase for AML Patients Receiving High-Dose Chemoterapy in Sweden

Emma Hernlund, PhD, Josefine Redig, MSc, Åsa Rangert Derolf, MD PhD, Bjorn Paulsson, MD, Martin Höglund, MD PhD, Simona Vertuani, PhD, Gunnar Juliusson, MD PhD

Blood (2019) 134 (Supplement_1): 2154.

https://doi.org/10.1182/blood-2019-127957

Published: 2019

Journal Articles

Hepatic Leukemia Factor Is Critical for Hematopoietic Stem Cells and Promotes MLL-AF9 Acute Myeloid Leukemia

Aurelie Baudet, PhD, Karolina Paulina Komorowska, PhD, Hultmark Simon, MS, Marcus Järås, PhD, Marion Chapellier, PhD, Gunnar Juliusson, MD PhD, Mattias Magnusson, PhD

Blood (2019) 134 (Supplement_1): 2466.

https://doi.org/10.1182/blood-2019-122661

Published: 2019

Journal Articles

AML Xenografts Undergo Extensive Clonal Competition and Unmask Rare Clones in Patient Samples

Carl Sandén, PhD, Henrik Lilljebjörn, PhD, Christina Orsmark-Pietras, PhD, Karim Saba, MSc, Carl Högberg, PhD, Marianne Rissler, MSc, Vladimir Lazarevic, MD PhD, Gunnar Juliusson, MD PhD, Helena Ågerstam, PhD, Thoas Fioretos, MD PhD

Blood (2018) 132 (Supplement 1): 2621.

https://doi.org/10.1182/blood-2018-99-110497

Published: 2018

Journal Articles

Monitoring Leukemic Mutations Using Ultrasensitive IBSAFE Digital Droplet Analysis Predicts Relapse of Acute Myeloid Leukemia

Louise Pettersson, MD, Yilun Chen, MSc, Anthony M George, MSc, Christina Orsmark-Pietras, PhD, Henrik Lilljebjörn, MSc, Robert Rigo, MSc, Vladimir Lazarevic, MD PhD, Thoas Fioretos, MD PhD, Gunnar Juliusson, MD PhD, Mats Ehinger, MD PhD, Lao H Saal, MD PhD

Blood (2017) 130 (Supplement 1): 3951.

https://doi.org/10.1182/blood.V130.Suppl_1.3951.3951

Published: 2017

Journal Articles

Monitoring Minimal Residual Disease in AML By Patient Specific Mutational Fingerprint Using Multiplex PCR and Deep Sequencing

Christina Orsmark Pietras, Henrik Lilljebjörn, Vladimir Lazarevic, MD, Marianne Rissler, Mats Ehinger, Gunnar Juliusson, MD PhD, Thoas Fioretos

Blood (2016) 128 (22): 1715.

https://doi.org/10.1182/blood.V128.22.1715.1715

Published: 2016

Journal Articles

A Distributed International Patient Data Registry for Hairy Cell Leukemia

Leslie A. Andritsos, MD, Michael R. Grever, MD, Mirela Anghelina, MD, Claire E Dearden, MD FRCP, FRCPath, Monica Else, MA, MSc, James S. Blachly, MD, Omkar Lele, MS, MBA, Farhad Ravandi, MD, Clive S Zent, MD, James B. Johnston, MD FRCP, Versha Banerji, MD FRCP, Francesco Forconi, MD DM, PhD FRCPath, Anthony D. Ho, MD, Thorsten Zenz, Sascha Dietrich, Judit Demeter, MD PhD, Jacqueline C. Barrientos, MD, Jan A. Burger, MD PhD, Timothy G. Call, MD, Nicholas Chiorazzi, MD, Daniel J. DeAngelo, MD PhD, Julio Delgado, MD, Andrei Fagarasanu, MD PhD, Brunangelo Falini, Alessandro Gozzetti, MD, Jeffrey Jones, MD MPH, Gunnar Juliusson, MD, Eric H. Kraut, MD, Robert J. Kreitman, MD, Loree Larratt, MD, Francesco Lauria, MD, Gerard Lozanski, MD, Emili Montserrat, MD, Sameer A. Parikh, MD, Jae H. Park, MD, Aaron Polliack, MD, Graeme R. Quest, MD MSc, Kanti R. Rai, MD, Tadeusz Robak, MD PhD, Alan Saven, MD, Tamar Tadmor, MD, Martin S. Tallman, MD, Constantine S. Tam, MBBS, Enrico Tiacci, MD, Xavier Troussard, MD PhD, Omar Abdel-Wahab, MD, Pier Luigi Zinzani, MD, PhD, Christopher Heckler, BS, MBA, Philip R.O. Payne, PhD

Blood (2016) 128 (22): 5986.

https://doi.org/10.1182/blood.V128.22.5986.5986

Published: 2016

Journal Articles

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

Blood (2016) 128 (22): 2686.

https://doi.org/10.1182/blood.V128.22.2686.2686

Published: 2016

Journal Articles

ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome

Blood (2015) 126 (23): 1712.

https://doi.org/10.1182/blood.V126.23.1712.1712

Published: 2015

Journal Articles

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, Petar Antunovic, MD, Asa Rangert Derolf, MDPhD, Hege Garelius, MD, Sören Lehmann, Prof, Kristina Myhr-Eriksson, MD, Lars Möllgård, MDPhD, Bertil Uggla, MDPhD, Anders Wahlin, Prof, Lovisa Wennström, MD PhD, Martin Höglund, Ass Prof

Blood (2015) 126 (23): 4888.

https://doi.org/10.1182/blood.V126.23.4888.4888

Published: 2015

Journal Articles

Comprehensive Prospective Next Generation Sequencing of Acute Myeloid Leukemia

Christina Orsmark-Pietras, Henrik Lilljebjörn, Marianne Rissler, Vladimir Lazarevic, Alexandros Arvanitakis, Mats Ehinger, Gunnar Juliusson, MD PhD, Thoas Fioretos

Blood (2015) 126 (23): 3830.

https://doi.org/10.1182/blood.V126.23.3830.3830

Published: 2015

Journal Articles

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Stefan Deneberg, MD, PhD, Ebba Lundin, Vladimir Lazarevic, Lina Benson, Bertil Uggla, MDPhD, Petar Antunovic, MD, Lars Mollgard, Sören Lehmann, Prof, Gunnar Juliusson, MD PhD, Martin Höglund, Ass Prof, Asa Rangert Derolf, MDPhD

Blood (2015) 126 (23): 3748.

https://doi.org/10.1182/blood.V126.23.3748.3748

Published: 2015

Journal Articles

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Gunnar Juliusson, MD PhD, Vladimir Lazarevic, MD, Sören Lehmann, MD PhD, Åsa Rangert Derolf, MD PhD, Lars Möllgård, MDPhD, Hege Garelius, MD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD

Blood (2014) 124 (21): 2269.

https://doi.org/10.1182/blood.V124.21.2269.2269

Published: 2014

Journal Articles

Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia

Blood (2014) 124 (21): 297.

https://doi.org/10.1182/blood.V124.21.297.297

Published: 2014

Journal Articles

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Christer Nilsson, MD, Erik Hulegårdh, MD, Vladimir Lazarevic, MD, Hege Garelius, MD, Asa Rangert Derolf, MDPhD, Lars Möllgård, MDPhD, Lovisa Wennström, MD PhD, Bertil Uggla, MD PhD, Petar Antunovic, MD, Kristina Myhr-Eriksson, MD, Anders Wahlin, MD PhD, Martin Höglund, MDPhD, Gunnar Juliusson, MD PhD, Dick Stockelberg, MD PhD, Lehmann Soren, MD PhD

Blood (2014) 124 (21): 281.

https://doi.org/10.1182/blood.V124.21.281.281

Published: 2014

Journal Articles

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Cecilie Blimark, MD, Erik Holmberg, PhD, Gunnar Juliusson, MD, PhD, Hareth Nahi, MD, PhD, Forsberg Karin, MD, PhD, Ingemar Turesson, MD, PhD, Lucia Ahlberg, MD., PhD., Ronald Svensson, MD, Olle Linder, MD, Kristina Carlsson, MD, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1972.

https://doi.org/10.1182/blood.V122.21.1972.1972

Published: 2013

Journal Articles

Differential Distribution Of Recurrent Gene Mutations In Subsets Of Chronic Lymphocytic Leukemia Patients With Stereotyped B-Cell Receptors: Results From A Multicenter Project Of The European Research Initiative On CLL In A Series Of 2482 Cases

Blood (2013) 122 (21): 4113.

https://doi.org/10.1182/blood.V122.21.4113.4113

Published: 2013

Journal Articles

Strong Therapeutic Effect Of Anti-IL1RAP Immunotherapy In a Xenograft Model Of Acute Myeloid Leukemia

Helena Agerstam, PhD, Maria Askmyr, PhD, Nils Hansen, Marianne Rissler, Gunnar Juliusson, MD, PhD, Johan Richter, MD, PhD, Mark Wunderlich, MS, Marcus Järås, PhD, James C. Mulloy, PhD, Thoas Fioretos, MD PhD

Blood (2013) 122 (21): 3954.

https://doi.org/10.1182/blood.V122.21.3954.3954

Published: 2013

Journal Articles

Novel Gene Mutations In Chronic Lymphocytic Leukemia: Prevalence and Clinical Implications In A Series Of 3185 Cases - Initial Results From The European Research Initiative On CLL

Blood (2013) 122 (21): 1614.

https://doi.org/10.1182/blood.V122.21.1614.1614

Published: 2013

Journal Articles

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Soren Lehmann, MD, PhD, Vladimir Lazarevic, MD, Ann-Sofi Hörstedt, Erik Hulegårdh, MD, Christer Nilsson, MD, Petar Antunovic, MD, Åsa Rangert Derolf, MD, PhD, Lars Möllgård, MD, PhD, Bertil Uggla, MD, PhD, Lovisa Vennström, MD, Anders Wahlin, MD, PhD, Martin Hoglund, MD, PhD, Dick Stockelberg, MD, PhD, Gunnar Juliusson, MD, PhD

Blood (2012) 120 (21): 130.

https://doi.org/10.1182/blood.V120.21.130.130

Published: 2012

Journal Articles

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Meral Beksac, MD, Anders Waage, MD, PhD, Sara Bringhen, MD, Sigurdur Y Kristinsson, MD PhD, Gulsan Sucak, MD, Peter Gimsing, MD, PhD, Lupparelli Giulia, PhD, Tulin Firatli Tuglular, MD, Gunnar Juliusson, MD PhD, Antonio Palumbo, MD

Blood (2011) 118 (21): 3970.

https://doi.org/10.1182/blood.V118.21.3970.3970

Published: 2011

NARROW

Costs per Treatment Phase for AML Patients Receiving High-Dose Chemoterapy in Sweden

Hepatic Leukemia Factor Is Critical for Hematopoietic Stem Cells and Promotes MLL-AF9 Acute Myeloid Leukemia

AML Xenografts Undergo Extensive Clonal Competition and Unmask Rare Clones in Patient Samples

Monitoring Leukemic Mutations Using Ultrasensitive IBSAFE Digital Droplet Analysis Predicts Relapse of Acute Myeloid Leukemia

Monitoring Minimal Residual Disease in AML By Patient Specific Mutational Fingerprint Using Multiplex PCR and Deep Sequencing

A Distributed International Patient Data Registry for Hairy Cell Leukemia

DNA Copy Number Gains of TCF4 (E2-2) Are Associated with Poor Outcome in Diffuse Large B-Cell Lymphoma

ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome

Prevalence and Characteristics of Survivors from Adult Acute Myeloid Leukemia (AML) in Sweden 2014

Comprehensive Prospective Next Generation Sequencing of Acute Myeloid Leukemia

Reasons for Decreasing Early Mortality in Acute Myeloid Leukemia: An Epidemiological Study from the Swedish Acute Leukemia Registry

Improved Survival of Patients with Acute Myeloid Leukemia Following Implementation of Swedish National Guidelines: Results from the AML Registry 1997-2013

Recurrent Mutations within the Nfkbie gene: A Novel Mechanism for NF-κB Deregulation in Aggressive Chronic Lymphocytic Leukemia

Allogeneic Transplantation in First Remission Improves Outcome in Secondary Acute Myeloid Leukemia

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Differential Distribution Of Recurrent Gene Mutations In Subsets Of Chronic Lymphocytic Leukemia Patients With Stereotyped B-Cell Receptors: Results From A Multicenter Project Of The European Research Initiative On CLL In A Series Of 2482 Cases

Strong Therapeutic Effect Of Anti-IL1RAP Immunotherapy In a Xenograft Model Of Acute Myeloid Leukemia

Novel Gene Mutations In Chronic Lymphocytic Leukemia: Prevalence and Clinical Implications In A Series Of 3185 Cases - Initial Results From The European Research Initiative On CLL

Poor Outcome in Secondary Acute Myeloid Leukemia (AML): A First Report From the Population-Based Swedish Acute Leukemia Registry

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only